Coen Kuijl is assistant professor of Medical Microbiology and Infection Control at the VU university medical center. After his MSc study in Medical Biology at VU University and Harvard, he completed his PhD Cum Laude in Cell/Cellular and Molecular Biology at the Dutch Cancer Institute (NKI) and Leiden University in 2008. He then held a postdoc position in Immunology at the NKI until 2010. From 2010-2014 he held a Postdoc position at Genentech, San Fransisco. In 2014, he returned to the VU University as assistent professor.
Dr. Coen Kuijl's research examines the host-pathogen interface and employs genetic and cell biological approaches to understand these infections and their outcomes. This research focuses primarily on Salmonella, which is a common pathogen and powerful model organism for the study of infection. In addition to this basic research, dr. Kuijl's lab also examnies how host-pathogen interactions can be used (1) to improve BCG for treatment of bladder cancer, (2) to exploit BCG as a vaccine platform for protection against Tuberculosis and cancer and (3) to target antibiotica to the Q-fever containing compartment within cells to eradicate the pathogenic bacteria.